Trials & R&D · first seen 1h ago, updated 1h ago
Endpoints 11 2026 winner SonoThera has a new approach to non-viral gene therapy
Key leaders Kenneth Greenberg (CEO), Steve Feinstein (CSO) Headquarters San Francisco Total raised $186M Key investors Vida Ventures, ARCH Ventures Partners, Illumina Ventures, Leaps by Bayer, Johnson & Johnson Innovation, Eli Lilly ...
Summary from Endpoints News.